Literature DB >> 17957396

Multiple cerebral cavernous malformations associated with extracranial mesenchymal anomalies.

Ardavan Ardeshiri1, Ardeshir Ardeshiri, Andres Beiras-Fernandez, Ortrud K Steinlein, Peter A Winkler.   

Abstract

Cerebral cavernous malformations (CCM) are common hamartous dysplasias characterized by abnormally dilated vascular channels. CCM mostly occur sporadically, and multiple occurrence of CCM is highly suggestive of a genetic origin of the disorder. Typical clinical symptoms are seizures, hemorrhages, focal neurological deficits, and headaches. Three genes have so far been described that are responsible for most cases of familial CCM and more than half of the sporadic cases with multiple CCM (CCM1-3). The coincidence of CCM and other vascular anomalies has been described before. The present review discusses the association of CCM with mesenchymal anomalies, with special emphasis on the possible common pathogenetic pathway for CCM and atrial myxomas. An illustrative case is presented in which CCM occurred together with different dysplasias (multiple CCM, liver cavernoma, and cardiac atrial myxoma), which are all thought to arise from abnormal mesenchymal cell differentiation processes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17957396     DOI: 10.1007/s10143-007-0111-7

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  63 in total

Review 1.  Update on the molecular genetics of vascular anomalies.

Authors:  Qing K Wang
Journal:  Lymphat Res Biol       Date:  2005       Impact factor: 2.589

Review 2.  [131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies].

Authors:  P Otten; G P Pizzolato; B Rilliet; J Berney
Journal:  Neurochirurgie       Date:  1989       Impact factor: 1.553

Review 3.  Vascular malformations and epilepsy: clinical considerations and basic mechanisms.

Authors:  D L Kraemer; I A Awad
Journal:  Epilepsia       Date:  1994       Impact factor: 5.864

4.  Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.

Authors:  L S Kirschner; J A Carney; S D Pack; S E Taymans; C Giatzakis; Y S Cho; Y S Cho-Chung; C A Stratakis
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

5.  An association between autosomal dominant cerebral cavernomas and a distinctive hyperkeratotic cutaneous vascular malformation in 4 families.

Authors:  P Labauge; O Enjolras; J J Bonerandi; S Laberge; M Dandurand; J M Joujoux; E Tournier-Lasserve
Journal:  Ann Neurol       Date:  1999-02       Impact factor: 10.422

6.  Spinal cord cavernous malformation in a patient with familial intracranial cavernous malformations.

Authors:  K S Lee; R F Spetzler
Journal:  Neurosurgery       Date:  1990-05       Impact factor: 4.654

7.  Mixed vascular malformations of the brain: clinical and pathogenetic considerations.

Authors:  I A Awad; J R Robinson; S Mohanty; M L Estes
Journal:  Neurosurgery       Date:  1993-08       Impact factor: 4.654

8.  Cavernous hemangioma of the retina, cutaneous angiomas, and intracranial vascular lesion by computed tomography and nuclear magnetic resonance imaging.

Authors:  A C Schwartz; R G Weaver; R Bloomfield; M E Tyler
Journal:  Am J Ophthalmol       Date:  1984-10-15       Impact factor: 5.258

Review 9.  Cavernous malformations of the brain stem. A review of 139 cases.

Authors:  J A Fritschi; H J Reulen; R F Spetzler; J M Zabramski
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

10.  Mutations within the MGC4607 gene cause cerebral cavernous malformations.

Authors:  C Denier; S Goutagny; P Labauge; V Krivosic; M Arnoult; A Cousin; A L Benabid; J Comoy; P Frerebeau; B Gilbert; J P Houtteville; M Jan; F Lapierre; H Loiseau; P Menei; P Mercier; J J Moreau; A Nivelon-Chevallier; F Parker; A M Redondo; J M Scarabin; M Tremoulet; M Zerah; J Maciazek; E Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2004-01-22       Impact factor: 11.025

View more
  6 in total

Review 1.  Cystic cavernous angiomas.

Authors:  Shigeo Ohba; Kazuhiko Shimizu; Syunsuke Shibao; Toru Nakagawa; Hideki Murakami
Journal:  Neurosurg Rev       Date:  2010-02-20       Impact factor: 3.042

2.  Neurological manifestations of atrial myxoma and stereotactic radiosurgery for metastatic aneurysms.

Authors:  Melanie Hau; Tak Lap Poon; Fung Ching Cheung
Journal:  J Radiosurg SBRT       Date:  2020

3.  CCM3 Loss-Induced Lymphatic Defect Is Mediated by the Augmented VEGFR3-ERK1/2 Signaling.

Authors:  Lingfeng Qin; Haifeng Zhang; Busu Li; Quan Jiang; Francesc Lopez; Wang Min; Jenny Huanjiao Zhou
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-10-21       Impact factor: 8.311

4.  Familial cerebral cavernous malformation: report of a further Italian family.

Authors:  Serena Nannucci; Francesca Pescini; Anna Poggesi; Laura Ciolli; Maria Cristina Patrosso; Alessandro Marocchi; Domenico Inzitari; Silvana Penco; Leonardo Pantoni
Journal:  Neurol Sci       Date:  2009-01-30       Impact factor: 3.307

5.  Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.

Authors:  Rebecca A Stockton; Robert Shenkar; Issam A Awad; Mark H Ginsberg
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

6.  Neuroimaging characteristics and long-term prognosis of myxoma-related intracranial diseases.

Authors:  Shuo Zhang; Qian Zhang; Hai Yu; Longqi Liu; Rujing Sun; Xiaowen Song; Xianzeng Tong; Yueshan Piao; Xin Chen; Jun Wu; Yong Cao; Shuo Wang; Jizong Zhao
Journal:  Neuroradiology       Date:  2019-11-12       Impact factor: 2.804

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.